文献速递中枢神经肿瘤放疗放疗物理与技术

4π计划优化用于皮质保护性脑放疗

4π plan optimization for cortical-sparing brain radiotherapy.
PubMed 文献 · Radiother Oncol · 2018-03-05

该研究对13例既往接受过放疗的脑肿瘤患者的原始IMRT计划进行再计划,分别采用4π优化和优化IMRT以保护皮质。在匹配PTV覆盖的前提下,4π较优化IMRT显著改善均匀性指数(27%,p=0.005)和梯度指数(8%,p=0.001),并降低海马EUD(14-15%,p≤0.003)及皮质、白质剂量。基于剂量反应模型,4π使1、2、3级皮质萎缩概率较原始IMRT分别降低12%、21%、26%(p≤0.001)。

要点

  • 4π优化在匹配PTV覆盖下改善剂量均匀性和梯度,优于优化IMRT。
  • 4π降低海马EUD及皮质、白质受照剂量,保护标准OAR。
  • 模型预测4π可降低治疗后皮质萎缩概率,可能减少认知下降风险。

核心结论

  • 4π放疗显著改善皮质保护并降低标准脑OAR、白质和海马剂量,同时获得更优的PTV剂量均匀性。
  • 这种保护可能降低皮质萎缩概率,从而可能减少认知下降。

研究设计与样本

  • 对13例既往接受过放疗的脑肿瘤患者的原始IMRT计划进行再计划,分别采用4π优化和优化IMRT以保护皮质。
  • 在匹配PTV覆盖条件下比较均匀性指数、梯度指数、皮质和白质(排除肿瘤)、脑干、视路及海马剂量。
  • 基于已建立的剂量反应曲线建模三种级别治疗后皮质萎缩的概率。

主要发现

  • 4π较优化IMRT显著改善均匀性指数27%(p=0.005)和梯度指数8%(p=0.001)。
  • 4π降低所有标准OAR的 mean dose 和等效均匀剂量(EUD),海马EUD较其他两个计划降低14-15%(p≤0.003)。
  • 4π较原始IMRT显著降低皮质部分体积剂量(V50、V40、V30),较优化IMRT降低皮质V30 7%(p=0.008)。
  • 4π的白质EUD、mean dose及V50、V40、V30也显著更低(p≤0.001)。
  • 4π使1、2、3级皮质萎缩概率较原始IMRT分别降低12%、21%、26%,较优化IMRT分别降低8%、14%、3%(p≤0.001)。

关键数值与推荐

  • 均匀性指数改善27%(p=0.005),梯度指数改善8%(p=0.001),均为4π对比优化IMRT。
  • 海马EUD降低14-15%(p≤0.003),4π对比其他两个计划。
  • 皮质V30降低7%(p=0.008),4π对比优化IMRT。
  • 白质EUD、mean dose及V50、V40、V30显著更低(p≤0.001),4π对比其他计划。
  • 1、2、3级皮质萎缩概率分别降低12%、21%、26%(较原始IMRT)和8%、14%、3%(较优化IMRT),p≤0.001。

临床怎么用

  • 对于需脑放疗且关注认知功能保护的患者,可考虑采用4π优化以保护皮质和海马。
  • 4π优化可在不牺牲PTV覆盖和均匀性的前提下降低皮质、白质及海马剂量。
  • 基于剂量反应模型,4π可能降低皮质萎缩概率,但需临床研究验证其对认知下降的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Incidental irradiation of normal brain tissue during radiotherapy is linked to cognitive decline, and may be mediated by damage to healthy cortex. Non-coplanar techniques may be used for cortical sparing. We compared normal brain sparing and probability of cortical atrophy using 4π radiation therapy planning vs. standard fixed gantry intensity-modulated radiotherapy (IMRT). MATERIAL AND METHODS: Plans from previously irradiated brain tumor patients ("original IMRT", n = 13) were re-planned to spare cortex using both 4π optimization ("4π") and IMRT optimization ("optimized IMRT"). Homogeneity index (HI), gradient measure, doses to cortex and white matter (excluding tumor), brainstem, optics, and hippocampus were compared with matching PTV coverage. Probability of three grades of post-treatment cortical atrophy was modeled based on previously established dose response curves. RESULTS: With matching PTV coverage, 4π significantly improved HI by 27% (p = 0.005) and gradient measure by 8% (p = 0.001) compared with optimized IMRT. 4π optimization reduced mean and equivalent uniform doses (EUD) to all standard OARs, with 14-15% reduction in hippocampal EUD (p ≤ 0.003) compared with the other two plans. 4π significantly reduced dose to fractional cortical volumes (V50, V40 and V30) compared with the original IMRT plans, and reduced cortical V30 by 7% (p = 0.008) compared with optimized IMRT. White matter EUD, mean dose, and fractional volumes V50, V40 and V30 were also significantly lower with 4π (p ≤ 0.001). With 4π, probability of grade 1, 2 and 3 cortical atrophy decreased by 12%, 21% and 26% compared with original IMRT and by 8%, 14% and 3% compared with optimized IMRT, respectively (p ≤ 0.001). CONCLUSIONS: 4π radiotherapy significantly improved cortical sparing and reduced doses to standard brain OARs, white matter, and the hippocampus. This was achieved with superior PTV dose homogeneity. Such sparing could reduce the probability of cortical atrophy that may lead to cognitive decline.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Murzin VL, Woods K, Moiseenko V, et al. 4π plan optimization for cortical-sparing brain radiotherapy. Radiother Oncol. 2018. PMID: 29519628. doi:10.1016/j.radonc.2018.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。